Benoit Van den Eynde

University of Oxford

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (12)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (9)

Stanislas Goriely

Université libre de Bruxelles

BELGIUM

View details

Coralie Henin

Université libre de Bruxelles

BELGIUM

View details

Mads Gyrd-Hansen

Københavns Universitet

DENMARK

View details

Simon Klaessens

BELGIUM

View details

Jingjing Zhu

BELGIUM

View details

Stefan Naulaerts

Katholieke Universiteit Leuven

BELGIUM

View details

Jean-Francois Collet

Université catholique de Louvain

BELGIUM

View details

Laurent Gatto

Professor

Université catholique de Louvain

BELGIUM

View details

Abdulkader AZOUZ

Université libre de Bruxelles (ULB)

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Benoit Van den Eynde

Research Interests

Explore related searches

Contact this professor

Articles (12)

IFNγ-induced PD-L1+MHC II+ macrophages and Tim-3+ tumor-reactive CD8+ T cells predict a response to anti-PD-1 therapy in tumor-bearing mice

Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells

Tumour immune rejection triggered by activation of α2-adrenergic receptors

Metformin improves cancer immunotherapy by directly rescuing tumor-infiltrating CD8 T lymphocytes from hypoxia-induced immunosuppression

New Insights into the Mechanisms of Proteasome-Mediated Peptide Splicing Learned from Comparing Splicing Efficiency by Different Proteasome Subtypes

T Cell–Mediated Targeted Delivery of Anti–PD-L1 Nanobody Overcomes Poor Antibody Penetration and Improves PD-L1 Blocking at the Tumor Site

Navigating Critical Challenges Associated with Immunopeptidomics-Based Detection of Proteasomal Spliced Peptide Candidates

Arid5a: A Missing Link between EMT and Tumoral Immune Resistance

Tryptophanemia is controlled by a tryptophan-sensing mechanism ubiquitinating tryptophan 2,3-dioxygenase

TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism

Preclinical murine tumor models: A structural and functional perspective

Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors

Collaborators (9)

Stanislas Goriely

Coralie Henin

Mads Gyrd-Hansen

Simon Klaessens

Jingjing Zhu

Stefan Naulaerts

Jean-Francois Collet

Laurent Gatto

Abdulkader AZOUZ

Make your next move.